Background
Metabolic imaging using proton magnetic resonance spectroscopic imaging (MRSI) has increased the sensitivity and spectral resolution at field strengths of ≥7T. Compared to the conventional Cartesian‐based spectroscopic imaging, spiral trajectories enable faster data collection, promising the clinical translation of whole‐brain MRSI. Technical considerations at 7T, however, lead to a suboptimal sampling efficiency for the spiral‐out (SO) acquisitions, as a significant portion of the trajectory consists of rewinders.
Purpose
To develop and implement a spiral‐out‐in (SOI) trajectory for sampling of whole‐brain MRSI at 7T. We hypothesized that SOI will improve the signal‐to‐noise ratio (SNR) of metabolite maps due to a more efficient acquisition.
Study Type
Prospective.
Subjects/Phantom
Five healthy volunteers (28–38 years, three females) and a phantom.
Field Strength/Sequence
Navigated adiabatic spin‐echo spiral 3D MRSI at 7T.
Assessment
A 3D stack of SOI trajectories was incorporated into an adiabatic spin‐echo MRSI sequence with real‐time motion and shim correction. Metabolite spectral fitting, SNR, and Cramér–Rao lower bound (CRLB) were obtained. We compared the signal intensity and CRLB of three metabolites of tNAA, tCr, and tCho. Peak SNR (PSNR), structure similarity index (SSIM), and signal‐to‐artifact ratio were evaluated on water maps.
Statistical Tests
The nonparametric Mann–Whitney U‐test was used for statistical testing.
Results
Compared to SO, the SOI trajectory: 1) increased the k‐space sampling efficiency by 23%; 2) is less demanding for the gradient hardware, requiring 36% lower Gmax and 26% lower Smax; 3) increased PSNR of water maps by 4.94 dB (P = 0.0006); 4) resulted in a 29% higher SNR (P = 0.003) and lower CRLB by 26–35% (P = 0.02, tNAA), 35–55% (P = 0.03, tCr), and 22–23% (P = 0.04, tCho), which increased the number of well‐fitted voxels (eg, for tCr by 11%, P = 0.03). SOI did not significantly change the signal‐to‐artifact ratio and SSIM (P = 0.65) compared to SO.
Data Conclusion
SOI provided more efficient MRSI at 7T compared to SO, which improved the data quality and metabolite quantification.
Level of Evidence
1
Technical Efficacy Stage
2